Osteoporosis screening in postmenopausal women 50 to 64 years old: comparison of US Preventive Services Task Force strategy and two traditional strategies in the Women's Health Initiative
- PMID: 24431262
- PMCID: PMC4117254
- DOI: 10.1002/jbmr.2174
Osteoporosis screening in postmenopausal women 50 to 64 years old: comparison of US Preventive Services Task Force strategy and two traditional strategies in the Women's Health Initiative
Abstract
The US Preventive Services Task Force (USPSTF) recommends osteoporosis screening for women younger than 65 years whose 10-year predicted risk of major osteoporotic fracture is ≥ 9.3%. For identifying screening candidates among women aged 50 to 64 years, it is uncertain how the USPSTF strategy compares with the Osteoporosis Self-Assessment Tool (OST) and the Simple Calculated Osteoporosis Risk Estimate (SCORE). We examined data (1994 to 2012) from 5165 Women's Health Initiative participants aged 50 to 64 years. For the USPSTF (Fracture Risk Assessment Tool [FRAX] major fracture risk ≥ 9.3% calculated without bone mineral density [BMD]), OST (score <2), and SCORE (score >7) strategies, we assessed sensitivity, specificity, and area under the receiver operating characteristic curve (AUC) to discriminate between those with and without femoral neck (FN) T-score ≤-2.5. Sensitivity, specificity, and AUC for identifying FN T-score ≤-2.5 were 34.1%, 85.8%, and 0.60 for USPSTF (FRAX); 74.0%, 70.8%, and 0.72 for SCORE; and 79.8%, 66.3%, and 0.73 for OST. The USPSTF strategy identified about one-third of women aged 50 to 64 years with FN T-scores ≤-2.5. Among women aged 50 to 64 years, the USPSTF strategy was modestly better than chance alone and inferior to conventional SCORE and OST strategies in discriminating between women with and without FN T-score ≤-2.5.
Keywords: BONE MINERAL DENSITY; FRACTURE; FRACTURE RISK ASSESSMENT TOOL; OSTEOPOROSIS; USPSTF, OST, SCORE, FRAX.
© 2014 American Society for Bone and Mineral Research.
Figures
Similar articles
-
Race and Ethnicity and Fracture Prediction Among Younger Postmenopausal Women in the Women's Health Initiative Study.JAMA Intern Med. 2023 Jul 1;183(7):696-704. doi: 10.1001/jamainternmed.2023.1253. JAMA Intern Med. 2023. PMID: 37213092 Free PMC article.
-
Comparison of fracture risk prediction by the US Preventive Services Task Force strategy and two alternative strategies in women 50-64 years old in the Women's Health Initiative.J Clin Endocrinol Metab. 2014 Dec;99(12):4514-22. doi: 10.1210/jc.2014-2332. J Clin Endocrinol Metab. 2014. PMID: 25322268 Free PMC article.
-
Comparison of Clinical Risk Tools for Predicting Osteoporosis in Women Ages 50-64.J Am Board Fam Med. 2016 Mar-Apr;29(2):233-9. doi: 10.3122/jabfm.2016.02.150237. J Am Board Fam Med. 2016. PMID: 26957380
-
Risk Assessment Tools for Osteoporosis Screening in Postmenopausal Women: A Systematic Review.Curr Osteoporos Rep. 2015 Oct;13(5):287-301. doi: 10.1007/s11914-015-0282-z. Curr Osteoporos Rep. 2015. PMID: 26233285 Review.
-
Is BMD testing appropriate for all menopausal women?Int J Fertil Womens Med. 2005 Mar-Apr;50(2):61-6. Int J Fertil Womens Med. 2005. PMID: 16334412 Review.
Cited by
-
Femoral osteoporosis prediction model using autosegmentation and machine learning analysis with PyRadiomics on abdomen-pelvic computed tomography (CT).Quant Imaging Med Surg. 2024 Jun 1;14(6):3959-3969. doi: 10.21037/qims-23-1751. Epub 2024 May 8. Quant Imaging Med Surg. 2024. PMID: 38846273 Free PMC article.
-
A novel primary osteoporosis screening tool (POST) for adults aged 50 years and over.Endocrine. 2023 Oct;82(1):190-200. doi: 10.1007/s12020-023-03442-3. Epub 2023 Jul 14. Endocrine. 2023. PMID: 37450217
-
Executive summary: Italian guidelines for diagnosis, risk stratification, and care continuity of fragility fractures 2021.Front Endocrinol (Lausanne). 2023 Apr 18;14:1137671. doi: 10.3389/fendo.2023.1137671. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37143730 Free PMC article.
-
A systematic review on the performance of fracture risk assessment tools: FRAX, DeFRA, FRA-HS.J Endocrinol Invest. 2023 Nov;46(11):2287-2297. doi: 10.1007/s40618-023-02082-8. Epub 2023 Apr 9. J Endocrinol Invest. 2023. PMID: 37031450 Free PMC article.
-
Design of a Computer Model for the Identification of Adolescent Swimmers at Risk of Low BMD.Int J Environ Res Public Health. 2023 Feb 16;20(4):3454. doi: 10.3390/ijerph20043454. Int J Environ Res Public Health. 2023. PMID: 36834149 Free PMC article.
References
-
- Screening for osteoporosis: U.S. preventive services task force recommendation statement. Ann Intern Med. 2011;154(5):356–64. - PubMed
-
- World Health Organization Collaborating Centre for Metabolic Bone Diseases UoS, UK . FRAX WHO Fracture Risk Assessment Tool, vol. 2012. World Health Organization Collaborating Centre for Metabolic Bone Diseases. University of Sheffield; UK: 2009.
-
- Cadarette SM, McIsaac WJ, Hawker GA, Jaakkimainen L, Culbert A, Zarifa G, Ola E, Jaglal SB. The validity of decision rules for selecting women with primary osteoporosis for bone mineral density testing. Osteoporos Int. 2004;15(5):361–6. - PubMed
-
- Geusens P, Hochberg MC, van der Voort DJ, Pols H, van der Klift M, Siris E, Melton ME, Turpin J, Byrnes C, Ross P. Performance of risk indices for identifying low bone density in postmenopausal women. Mayo Clin Proc. 2002;77(7):629–37. - PubMed
-
- Gourlay ML, Miller WC, Richy F, Garrett JM, Hanson LC, Reginster JY. Performance of osteoporosis risk assessment tools in postmenopausal women aged 45-64 years. Osteoporos Int. 2005;16(8):921–7. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous